No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NUS240517P15000
- 1.25
- -1.55-55.36%
15min DelayTrading May 14 09:50 ET
1.25High1.25Low
1.25Open2.80Pre Close50 Volume49 Open Interest15.00Strike Price6.25KTurnover93.30%IV-0.29%PremiumMay 17, 2024Expiry Date1.19Intrinsic Value100Multiplier3DDays to Expiry0.07Time Value100Contract SizeAmericanOptions Type-0.7791Delta0.2307Gamma11.28Leverage Ratio-0.0524Theta-0.0011Rho-8.79Eff Leverage0.0041Vega
Intraday
- 5D
- 1D
News
Even After Rising 8.4% This Past Week, Nu Skin Enterprises (NYSE:NUS) Shareholders Are Still Down 75% Over the Past Three Years
Nu Skin Enterprises Repeat Insider Selling Not A Positive Indicator
Quite a few Nu Skin Enterprises, Inc. (NYSE:NUS) insiders sold their shares over the past year, which may be a cause for concern. Knowing whether insiders are buying is usually more helpful when eva
Nu Skin Enterprises Inc (NUS) Q1 Earnings: Aligns With EPS Projections Amidst Revenue Decline
Nu Skin Enterprises | 10-Q: Quarterly report
Nu Skin Is Maintained at Neutral by DA Davidson
Nu Skin Is Maintained at Neutral by DA Davidson
Nu Skin Enterprises Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 0.93% DA Davidson $15.5 → $12.5 Maintains Neutral 01/05/2024 69.56% DA Davidson $29 → $21 Maint
Comments
Nu Skin Enterprises' low P/S ratio is likely due to anticipated poor revenue performance. Its shrinking revenues and weak outlook, contrasting with expected industry growth, justify its low P/S ratio and hint at a stagnant share price.
Benign Growth For Nu Skin Enterprises, Inc. (NYSE:NUS) Underpins Stock's 28% PlummetAnalysts are more bearish on Nu Skin Enterprises' prospects, with a significant cut to revenue and EPS estimates. The company's slower expected revenue growth compared to the wider market could worry investors.
Despite a mixed Q3, personal care stocks have held their ground better than other sectors, with share prices up 18.5% on average since the previous earnings results. Coty's stock is up 20.9%, Olaplex's stock is up 74.6%, Nu Skin's stock is down 0.1%, Herbalife's stock is down 9.8%, and BellRing Brands' stock is up 22.3%.
Read more